Cover Image
Market Research Report

Urology Market Analysis, Size, Trends | Australia | MedSuite

Published by iData Research Inc. Product code 918707
Published Content info 387 Pages
Delivery time: 1-2 business days
Price
Back to Top
Urology Market Analysis, Size, Trends | Australia | MedSuite
Published: November 1, 2019 Content info: 387 Pages
Description

The full report suite on the Australian market for the urological devices includes urinary incontinence devices, pelvic organ prolapse treatment, stone management devices, benign prostate hyperplasia (BPH) treatment devices and erectile dysfunction devices.

The BPH treatment market and the stone management device market accounted for the majority of the total market value in 2019. The growth in these two segments is driven by the stable demand for related procedures, the growing prevalence of prostatic and kidney diseases and the premium prices for lasers and lithotripters.

Table of Contents
Product Code: iDATA_AUUR20_MS

TABLE OF CONTENTS

TABLE OF CONTENTS I

LIST OF FIGURES X

LIST OF CHARTS XIX

EXECUTIVE SUMMARY 1

AUSTRALIA UROLOGICAL DEVICE MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 3

MARKET TRENDS 6

MARKET DEVELOPMENTS 7

PROCEDURE NUMBERS 8

MARKETS INCLUDED 9

VERSION HISTORY 10

RESEARCH METHODOLOGY 11

  • Step 1: Project Initiation & Team Selection 11
  • Step 2: Prepare Data Systems and Perform Secondary Research 14
  • Step 3: Preparation for Interviews & Questionnaire Design 16
  • Step 4: Performing Primary Research 17
  • Step 5: Research Analysis: Establishing Baseline Estimates 19
  • Step 6: Market Forecast and Analysis 20
  • Step 7: Identify Strategic Opportunities 22
  • Step 8: Final Review and Market Release 23
  • Step 9: Customer Feedback and Market Monitoring 24

DISEASE OVERVIEW 25

  • 2.1 BASIC ANATOMY 25
    • 2.1.1 Urinary System 25
      • 2.1.1.1 Male Urinary System 26
      • 2.1.1.2 Female Urinary System 27
  • 2.2 DISEASE TREATMENT AND DIAGNOSTICS 28
    • 2.2.1 Benign Prostatic Hyperplasia 28
    • 2.2.2 Urinary Incontinence 29
    • 2.2.3 Urinary Tract Infections 31
    • 2.2.4 Kidney Stones 32
    • 2.2.5 Bladder Prolapse 34
    • 2.2.6 Overactive Bladder 35
    • 2.2.7 Prostatitis 36
    • 2.2.8 Erectile Dysfunction 38
    • 2.2.9 Cancer 39
      • 2.2.9.1 Prostate Cancer 39
      • 2.2.9.2 Bladder Cancer 40
    • 2.2.10 Indications for Pelvic Organ Prolapse Repair 41
  • 2.3 PATIENT DEMOGRAPHICS 42

PRODUCT ASSESSMENT 44

  • 3.1 INTRODUCTION 44
  • 3.2 PRODUCT PORTFOLIOS 44
    • 3.2.1 Urinary Incontinence 44
      • 3.2.1.1 Urinary Catheters 44
      • 3.2.1.1.1 Intermittent Catheters 44
      • 3.2.1.1.2 Foley Catheters 45
      • 3.2.1.1.3 Male External Catheters 46
      • 3.2.1.2 Urethral Bulking Agents 47
      • 3.2.1.3 Incontinence Management Devices 48
      • 3.2.1.3.1 Female Incontinence Slings 48
      • 3.2.1.3.2 Male Implantable Devices 49
      • 3.2.1.4 Urine Bags 51
      • 3.2.1.4.1 Leg Bags 51
      • 3.2.1.4.2 Night Bags 51
    • 3.2.2 Pelvic Organ Prolapse Repair 56
      • 3.2.2.1 Autologous Tissue as an Alternative to Vaginal Mesh 57
      • 3.2.2.2 Product Matrix for Pelvic Organ Prolapse Repair 58
    • 3.2.3 Stone Management 59
      • 3.2.3.1 ESWL Equipment 59
      • 3.2.3.2 ISWL Equipment 60
      • 3.2.3.3 Holmium Lasers 60
      • 3.2.3.4 Stone Fragment Retrieval Devices 61
      • 3.2.3.5 Ureteral Stents 61
    • 3.2.4 BPH Treatment 65
      • 3.2.4.1 TURP 65
      • 3.2.4.2 TUMT 66
      • 3.2.4.3 TUNA 66
      • 3.2.4.4 Prostatic Stents 67
      • 3.2.4.5 Laser BPH 68
      • 3.2.4.5.1 Photoselective Vaporization of the Prostate (PVP) 69
      • 3.2.4.5.2 Laser Vaporization of the Prostate 70
      • 3.2.4.5.3 Laser Ablation of the Prostate 71
      • 3.2.4.5.4 Laser Resection of the Prostate 71
      • 3.2.4.5.5 Laser Enucleation of the Prostate 72
    • 3.2.5 Erectile Dysfunction 74
      • 3.2.5.1 Penile Implants 74
      • 3.2.5.1.1 Inflatable 74
      • 3.2.5.1.2 Malleable 75
      • 3.2.5.2 Vacuum 75
  • 3.3 REGULATORY ISSUES AND RECALLS 77
    • 3.3.1 Boston Scientific 77
      • 3.3.1.1 Stone Management 77
      • 3.3.1.2 Nephrostomy 79
    • 3.3.2 C. R. Bard (Becton Dickinson) 80
      • 3.3.2.1 Urinary Incontinence 80
      • 3.3.2.2 Stone Management 85
      • 3.3.2.3 Urological Endoscopes 85
      • 3.3.2.4 Prostate Cancer Treatment 85
      • 3.3.2.5 Nephrostomy 86
    • 3.3.3 Coloplast 88
      • 3.3.3.1 Urinary Catheter 88
      • 3.3.3.2 Erectile Dysfunction 88
    • 3.3.4 Cook Medical 89
      • 3.3.4.1 Stone Management 89
      • 3.3.4.2 Nephrostomy 90
    • 3.3.5 Elekta 92
      • 3.3.5.1 Prostate Cancer Treatment 92
    • 3.3.6 Karl Storz 93
      • 3.3.6.1 Urological Endoscopes 93
    • 3.3.7 Olympus 94
      • 3.3.7.1 Urological Endoscopes 94
  • 3.4 CLINICAL TRIALS 96
    • 3.4.1 Boston Scientific 96
      • 3.4.1.1 Urinary Incontinence 96
      • 3.4.1.2 BPH Treatment 97
      • 3.4.1.3 Urological endoscopes 98
      • 3.4.1.4 Nephrostomy 99
      • 3.4.1.5 Erectile Dysfunction 100
    • 3.4.2 C. R. Bard (Becton Dickinson) 101
      • 3.4.2.1 Urinary Incontinence 101
      • 3.4.2.2 Prostate Cancer Treatment 103
    • 3.4.3 Coloplast 104
      • 3.4.3.1 Urinary Incontinence 104
    • 3.4.4 Cook Medical 107
      • 3.4.4.1 Nephrostomy 107
    • 3.4.5 Elekta 109
      • 3.4.5.1 Prostate Cancer Treatment 109
    • 3.4.6 Ethicon 111
      • 3.4.6.1 Urinary Incontinence 111
    • 3.4.7 Karl Storz 113
      • 3.4.7.1 Stone Management 113
      • 3.4.7.2 Urological Endoscopes 115
    • 3.4.8 Laborie 118
      • 3.4.8.1 Urodynamics 118
    • 3.4.9 Medline 120
      • 3.4.9.1 Urinary Incontinence 120
    • 3.4.10 Olympus 121
      • 3.4.10.1 Stone Management 121
      • 3.4.10.2 BPH Treatment 122
      • 3.4.10.3 Urological Endoscopes 123

AUSTRALIA UROLOGICAL DEVICE MARKET OVERVIEW 125

  • 4.1 INTRODUCTION 125
  • 4.2 CURRENCY EXCHANGE RATE 126
  • 4.3 MARKET OVERVIEW 127
  • 4.4 TREND ANALYSIS BY SEGMENT 133
  • 4.5 DRIVERS AND LIMITERS 136
    • 4.5.1 Market Drivers 136
    • 4.5.2 Market Limiters 137
  • 4.6 COMPETITIVE MARKET SHARE ANALYSIS 140
  • 4.7 MERGERS AND ACQUISITIONS 147
  • 4.8 COMPANY PROFILES 149
    • 4.8.1 Boston Scientific 149
    • 4.8.2 C. R. Bard (Becton Dickinson) 151
    • 4.8.3 Coloplast 153
    • 4.8.4 Cook Medical 154
    • 4.8.5 Ethicon 155
    • 4.8.6 Karl Storz 156
    • 4.8.7 Laborie 157
    • 4.8.8 Olympus 158
  • 4.9 SWOT ANALYSIS 160
    • 4.9.1 Boston Scientific 161
    • 4.9.2 C. R. Bard (Becton Dickinson) 163
    • 4.9.3 Coloplast 165
    • 4.9.4 Cook Medical 166
    • 4.9.5 Ethicon 168
    • 4.9.6 Karl Storz 169
    • 4.9.7 Laborie 170
    • 4.9.8 Olympus 171

PROCEDURE NUMBERS 173

  • 5.1 PROCEDURE OVERVIEW 173
  • 5.2 URINARY INCONTINENCE PROCEDURES 180
    • 5.2.1 Male Incontinence Management Procedures 182
    • 5.2.2 Female Incontinence Management Procedures 185
  • 5.3 PELVIC ORGAN PROLAPSE REPAIR 188
  • 5.4 STONE MANAGEMENT PROCEDURES 190
    • 5.4.1 ESWL Procedures 192
    • 5.4.2 Transurethral Procedures 194
    • 5.4.3 Ureteral Stent Placement Procedures 196
    • 5.4.4 PCNL Procedures 198
  • 5.5 BPH PROCEDURES 200
    • 5.5.1 BPH Procedures 201
    • 5.5.2 Prostatectomy Procedures 203
  • 5.6 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 205

URINARY INCONTINENCE DEVICE MARKET 208

  • 6.1 INTRODUCTION 208
  • 6.2 MARKET OVERVIEW 209
  • 6.3 MARKET ANALYSIS AND FORECAST 214
    • 6.3.1 Total Urinary Catheter Market 214
      • 6.3.1.1 Intermittent Catheter Market 217
      • 6.3.1.2 Foley Catheter Market 219
      • 6.3.1.3 Male External Catheter Market 221
    • 6.3.2 Total Urethral Bulking Agent Market 223
      • 6.3.2.1 Male Urethral Bulking Agent Market 227
      • 6.3.2.2 Female Urethral Bulking Agent Market 229
    • 6.3.3 Total Incontinence Management Device Market 231
      • 6.3.3.1 Total Female Incontinence Sling Market 234
      • 6.3.3.1.1 Transvaginal Tape Female Incontinence Sling Market 240
      • 6.3.3.1.2 Transobturator Female Incontinence Sling Market 242
      • 6.3.3.1.3 Single-Incision Female Incontinence Sling Market 244
      • 6.3.3.2 Total Male Implantable Incontinence Device Market 246
      • 6.3.3.2.1 Male Incontinence Sling Market 251
      • 6.3.3.2.2 Male Artificial Urinary Sphincter Market 253
  • 6.4 DRIVERS AND LIMITERS 255
    • 6.4.1 Market Drivers 255
    • 6.4.2 Market Limiters 255
  • 6.5 COMPETITIVE MARKET SHARE ANALYSIS 258

PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET 264

  • 7.1 INTRODUCTION 264
  • 7.2 MARKET OVERVIEW 268
  • 7.3 MARKET ANALYSIS AND FORECAST 273
    • 7.3.1 Total Pelvic Organ Prolapse Repair Device Market 273
    • 7.3.2 Transvaginal Mesh Market 276
    • 7.3.3 Sacrocolpopexy Mesh Market 279
  • 7.4 DRIVERS AND LIMITERS 281
    • 7.4.1 Market Drivers 281
    • 7.4.2 Market Limiters 281
  • 7.5 COMPETITIVE MARKET SHARE ANALYSIS 283

STONE MANAGEMENT DEVICE MARKET 287

  • 8.1 INTRODUCTION 287
  • 8.2 MARKET OVERVIEW 290
  • 8.3 MARKET ANALYSIS AND FORECAST 296
    • 8.3.1 ESWL Equipment Market 296
    • 8.3.2 ISWL Equipment Market 299
    • 8.3.3 Total Holmium Laser Market 301
      • 8.3.3.1 Holmium Laser Equipment Market 304
      • 8.3.3.2 Holmium Laser Fiber Market 306
    • 8.3.4 Total Stone Fragment Retrieval Device Market 309
      • 8.3.4.1 Nitinol Stone Fragment Retrieval Device Market 314
      • 8.3.4.2 Stainless Steel Stone Fragment Retrieval Device Market 316
    • 8.3.5 Ureteral Stent Market 318
    • 8.3.6 Ureteral Guidewire Market 320
  • 8.4 DRIVERS AND LIMITERS 322
    • 8.4.1 Market Drivers 322
    • 8.4.2 Market Limiters 323
  • 8.5 COMPETITIVE MARKET SHARE ANALYSIS 325

BPH TREATMENT DEVICE MARKET 331

  • 9.1 INTRODUCTION 331
    • 9.1.1 Treatments 331
    • 9.1.2 Comparison of TURP and Laser BPH Procedures 333
    • 9.1.3 Emerging Technologies 333
  • 9.2 MARKET OVERVIEW 335
  • 9.3 MARKET ANALYSIS AND FORECAST 340
    • 9.3.1 Total TURP Market 340
      • 9.3.1.1 Monopolar Electrode Market 343
      • 9.3.1.2 Bipolar Electrode Market 345
    • 9.3.2 Total Laser BPH Market 347
      • 9.3.2.1 Laser BPH Equipment Market 350
      • 9.3.2.2 Laser BPH Fiber Market 352
    • 9.3.3 UroLift® Market 354
    • 9.3.4 Rezum® Market 356
  • 9.4 DRIVERS AND LIMITERS 358
    • 9.4.1 Market Limiters 359
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS 362

ERECTILE DYSFUNCTION DEVICE MARKET 366

  • 10.1 INTRODUCTION 366
    • 10.1.1 Low Testosterone Pharmaceutical Delivery 367
  • 10.2 MARKET OVERVIEW 368
  • 10.3 MARKET ANALYSIS AND FORECAST 373
    • 10.3.1 Inflatable Erectile Dysfunction Device Market 373
    • 10.3.2 Malleable Erectile Dysfunction Device Market 376
    • 10.3.3 Vacuum Erection Device Market 378
  • 10.4 DRIVERS AND LIMITERS 380
    • 10.4.1 Market Drivers 380
    • 10.4.2 Market Limiters 380
  • 10.5 COMPETITIVE MARKET SHARE ANALYSIS 382

ABBREVIATIONS 386

LIST OF CHARTS

  • Chart 1 1: Urological Device Market by Segment, Australia, 2016 - 2026 2
  • Chart 1 2: Urological Device Market by Segment, Australia, 2019 & 2026 2
  • Chart 4 1: Urological Device Market by Segment, Australia, 2016 - 2026 130
  • Chart 4 2: Urological Device Market Breakdown, Australia, 2019 131
  • Chart 4 3: Urological Device Market Breakdown, Australia, 2026 132
  • Chart 4 4: Growth Rates by Segment, Urological Device Market, Australia, 2016 - 2026 135
  • Chart 4 5: Leading Competitors, Urological Device Market, Australia, 2019 146
  • Chart 5 1: Urological Procedures by Type, Australia, 2016 - 2026 177
  • Chart 5 2: Urological Procedures by Type, Australia, 2019 178
  • Chart 5 3: Urological Procedures by Type, Australia, 2026 179
  • Chart 5 4: Urinary Incontinence Procedures by Type, Australia, 2016 - 2026 181
  • Chart 5 5: Male Incontinence Management Procedures by Type, Australia, 2015 - 2025 184
  • Chart 5 6: Female Incontinence Management Procedures by Type, Australia, 2016 - 2026 187
  • Chart 5 7: Pelvic Organ Prolapse Repair Procedures by Type, Australia, 2016 - 2026 189
  • Chart 5 8: Stone Management Procedures by Type, Australia, 2016 - 2026 191
  • Chart 5 9: ESWL Procedures, Australia, 2016 - 2026 193
  • Chart 5 10: Transurethral Procedures by Type, Australia, 2016 - 2026 195
  • Chart 5 11: Ureteral Stent Placement Procedures, Australia, 2016 - 2026 197
  • Chart 5 12: PCNL Procedures, Australia, 2016 - 2026 199
  • Chart 5 13: BPH Procedures by Type, Australia, 2016 - 2026 202
  • Chart 5 14: Prostatectomy Procedures by Type, Australia, 2016 - 2026 204
  • Chart 5 15: Erectile Dysfunction Management Procedures by Type, Australia, 2016 - 2026 207
  • Chart 6 1: Urinary Incontinence Device Market by Segment, Australia, 2016 - 2026 (US$M) 211
  • Chart 6 2: Urinary Incontinence Device Market by Segment, Australia, 2019 212
  • Chart 6 3: Urinary Incontinence Device Market by Segment, Australia, 2026 213
  • Chart 6 4: Urinary Catheter Market by Segment, Australia, 2016 - 2026 216
  • Chart 6 5: Intermittent Catheter Market, Australia, 2016 - 2026 218
  • Chart 6 6: Foley Catheter Market, Australia, 2016 - 2026 220
  • Chart 6 7: Male External Catheter Market, Australia, 2016 - 2026 222
  • Chart 6 8: Urethral Bulking Agent Market by Segment, Australia, 2016 - 2026 226
  • Chart 6 9: Male Urethral Bulking Agent Market, Australia, 2016 - 2026 228
  • Chart 6 10: Female Urethral Bulking Agent Market, Australia, 2016 - 2026 230
  • Chart 6 11: Incontinence Management Device Market by Segment, Australia, 2016 - 2026 233
  • Chart 6 12: Female Incontinence Sling Market by Type, Australia, 2016 - 2026 237
  • Chart 6 13: Total Female Incontinence Sling Market, Australia, 2016 - 2026 239
  • Chart 6 14: Transvaginal Tape Female Incontinence Sling Market, Australia, 2016 - 2026 241
  • Chart 6 15: Transobturator Female Incontinence Sling Market, Australia, 2016 - 2026 243
  • Chart 6 16: Single-Incision Female Incontinence Sling Market, Australia, 2016 - 2026 245
  • Chart 6 17: Male Implantable Incontinence Device Market by Segment, U.S., 2016 - 2026 248
  • Chart 6 18: Total Male Implantable Incontinence Device Market, Australia, 2016 - 2026 250
  • Chart 6 19: Male Incontinence Sling Market, Australia, 2016 - 2026 252
  • Chart 6 20: Male Artificial Urinary Sphincter Market, Australia, 2016 - 2026 254
  • Chart 6 21: Leading Competitors, Urinary Incontinence Device Market, Australia, 2019 263
  • Chart 7 1: Pelvic Organ Prolapse Repair Device Market by Segment, Australia, 2013 - 2023 271
  • Chart 7 2: Pelvic Organ Prolapse Repair Device Market Breakdown, Australia, 2019 & 2026 272
  • Chart 7 3: Pelvic Organ Prolapse Repair Device Market, Australia, 2016 - 2026 275
  • Chart 7 4: Transvaginal Mesh Market, Australia, 2016 - 2026 278
  • Chart 7 5: Sacrocolpopexy Mesh Market, Australia, 2016 - 2026 280
  • Chart 7 6: Leading Competitors, Pelvic Organ Prolapse Repair Market, Australia, 2019 286
  • Chart 8 1: Stone Management Device Market by Segment, Australia, 2016 - 2026 293
  • Chart 8 2: Stone Management Device Market Breakdown, Australia, 2019 294
  • Chart 8 3: Stone Management Device Market Breakdown, Australia, 2026 295
  • Chart 8 4: ESWL Equipment Market, Australia, 2016 - 2026 298
  • Chart 8 5: ISWL Equipment Market, Australia, 2016 - 2026 300
  • Chart 8 6: Holmium Laser Market by Segment, Australia, 2016 - 2026 303
  • Chart 8 7: Holmium Laser Equipment Market, Australia, 2016 - 2026 305
  • Chart 8 8: Holmium Laser Fiber Market, Australia, 2016 - 2026 308
  • Chart 8 9: Stone Fragment Retrieval Device Market by Segment, Australia, 2016 - 2026 311
  • Chart 8 10: Total Stone Fragment Retrieval Device Market, Australia, 2016 - 2026 313
  • Chart 8 11: Nitinol Stone Fragment Retrieval Device Market, Australia, 2016 - 2026 315
  • Chart 8 12: Stainless Steel Stone Fragment Retrieval Device Market, Australia, 2016 - 2026 317
  • Chart 8 13: Ureteral Stent Market, Australia, 2016 - 2026 319
  • Chart 8 14: Ureteral Guidewire Market, Australia, 2016 - 2026 321
  • Chart 8 15: Leading Competitors, Stone Management Device Market, Australia, 2019 330
  • Chart 9 1: BPH Treatment Device Market by Segment, Australia, 2016 - 2026 337
  • Chart 9 2: BPH Treatment Device Market Breakdown, Australia, 2019 338
  • Chart 9 3: BPH Treatment Device Market Breakdown, Australia, 2026 339
  • Chart 9 4: TURP Market by Segment, Australia, 2016 - 2026 342
  • Chart 9 5: Monopolar Electrode Market, Australia, 2016 - 2026 344
  • Chart 9 6: Bipolar Electrode Market, Australia, 2016 - 2026 346
  • Chart 9 7: Laser BPH Market by Segment, Australia, 2016 - 2026 349
  • Chart 9 8: Laser BPH Equipment Market, Australia, 2016 - 2026 351
  • Chart 9 9: Laser BPH Fiber Market, Australia, 2016 - 2026 353
  • Chart 9 10: UroLift Market, Australia, 2016 - 2026 355
  • Chart 9 11: Rezum Market, Australia, 2016 - 2026 357
  • Chart 9 12: Leading Competitors, BPH Treatment Market, Australia, 2019 365
  • Chart 10 1: Erectile Dysfunction Device Market by Segment, Australia, 2016 - 2026 370
  • Chart 10 2: Erectile Dysfunction Device Market Breakdown, Australia, 2019 371
  • Chart 10 3: Erectile Dysfunction Device Market Breakdown, Australia, 2026 372
  • Chart 10 4: Inflatable Erectile Dysfunction Device Market, Australia, 2016 - 2026 375
  • Chart 10 5: Malleable Erectile Dysfunction Device Market, Australia, 2016 - 2026 377
  • Chart 10 6: Vacuum Erection Device Market, U.S., 2016 - 2026 379
  • Chart 10 7: Leading Competitors, Erectile Dysfunction Device Market, Australia, 2019 385

LIST OF FIGURES

  • Figure 1 1: Urological Device Market Share Ranking by Segment, Australia, 2019 4
  • Figure 1 2: Companies Researched in this Report, Australia 5
  • Figure 1 3: Factors Impacting the Urological Device Market by Segment, Australia 6
  • Figure 1 4: Recent Events in the Urological Device Market, 2017 - 2019 7
  • Figure 1 5: Urological Procedures Covered, Australia 8
  • Figure 1 6: Urological Device Markets Covered, Australia (1 of 2) 9
  • Figure 1 7: Urological Device Markets Covered, Australia (2 of 2) 10
  • Figure 1 8: Version History 10
  • Figure 3 1: Urinary Incontinence Treatments by Company (1 of 3) 53
  • Figure 3 2: Urinary Incontinence Treatments by Company (2 of 3) 54
  • Figure 3 3: Urinary Incontinence Treatments by Company (3 of 3) 55
  • Figure 3 4: Stone Management Devices by Company (1 of 3) 62
  • Figure 3 5: Stone Management Devices by Company (2 of 3) 63
  • Figure 3 6: Stone Management Devices by Company (3 of 3) 64
  • Figure 3 7: BPH Treatments by Company 73
  • Figure 3 8: Erectile Dysfunction Devices by Company 76
  • Figure 3 9: Class 2 Device Recall Auriga Laser System 77
  • Figure 3 10: Class 2 Device Recall Fiber Strippers and Cleavers 78
  • Figure 3 11: Class 2 Device Recall StarMedTec LightTrail Reusable Fibers 79
  • Figure 3 12: Class 2 Device Recall Malecot Catheter Set 79
  • Figure 3 13: Class 2 Device Recall Encore(TM) 26 Inflation Device 79
  • Figure 3 14: Class 2 Device Recall Bardex Lubricath 3Way 75cc Continuous Irrigation Foley Catheter 80
  • Figure 3 15: Class 2 Device Recall Intermittent Catheters 80
  • Figure 3 16: Class 2 Device Recall leg bag 80
  • Figure 3 17: Class 2 Device Recall SURESTEP 81
  • Figure 3 18: Class 2 Device Recall PureWick External Catheter 81
  • Figure 3 19: Class 2 Device Recall SURESTEP Tray, BARDEX I.C. COMPLETE CARE, Urine Meter, Temperature STATLOCK Stabilization Device 81
  • Figure 3 20: Class 2 Device Recall BARD Irrigation Syringe, Rx Only, Sterile 82
  • Figure 3 21: Class 2 Device Recall Magic3 82
  • Figure 3 22: Class 2 Device Recall Optionvm Urinary Catheter. Male use only. Latex Free. Sterile, Rx only. 82
  • Figure 3 23: Class 3 Device Recall SureStep Tray, with AddaFoley 83
  • Figure 3 24: Class 2 Device Recall BARDEX 83
  • Figure 3 25: Class 3 Device Recall BARD Toomey Irrigation Syringe 70cc 83
  • Figure 3 26: Class 3 Device Recall Antibacterial Hydro Personal Catheter 83
  • Figure 3 27: Class 2 Device Recall Magic3 Intermittent Catheter with Sure Grip Hydrophilic Coated Silicone Coude tip 84
  • Figure 3 28: Class 2 Device Recall Magic3 Hydrophiliccoated Female Intermittent Catheter 84
  • Figure 3 29: Class 2 Device Recall Bard 100 LatexFree Urinary Drainage Bag with AntiReflux Chamber and Bard EXLok Sampling 84
  • Figure 3 30: Class 2 Device Recall Bard Dimension Stone Basket 85
  • Figure 3 31: Class 2 Device Recall CMax 85
  • Figure 3 32: Class 2 Device Recall Bard BrachySource Seed Implants 85
  • Figure 3 33: Class 2 Device Recall I125 CE Marked QuickLink Cartridges 86
  • Figure 3 34: Class 2 Device Recall Bard 86
  • Figure 3 35: Class 2 Device Recall XForce Nephrostomy Balloon Dilation Catheter Kit with Inflation Device 87
  • Figure 3 36: Class 2 Device Recall SelfCath Pediatric Catheter 88
  • Figure 3 37: Class 2 Device Recall Coloplast Conveen Urine Collection Leg Bag 88
  • Figure 3 38: Class 2 Device Recall Genesis Malleable Penile Prosthesis 88
  • Figure 3 39: Class 2 Device Recall StoneBreaker 89
  • Figure 3 40: Class 2 Device Recall OptiLite MultiUse Holmium Laser Fibers 89
  • Figure 3 41: Class 2 Device Recall Cook MultiUse Holmium Laser Fibers 90
  • Figure 3 42: Class 2 Device Recall Cook Bush 90
  • Figure 3 43: Class 2 Device Recall Aprima" Access Nonvascular Introducer Set 90
  • Figure 3 44: Class 2 Device Recall Ascend AQ 91
  • Figure 3 45: Class 2 Device Recall Oncentra Brachy 4.5 92
  • Figure 3 46: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 92
  • Figure 3 47: Class 2 Device Recall Oncentra External Beam Treatment Planning Software 92
  • Figure 3 48: Class 2 Device Recall Oncentra Brachy treatment planning system 92
  • Figure 3 49: Class 2 Device Recall STORZ High Flow Insufflation Tubing (with filter) 93
  • Figure 3 50: Class 2 Device Recall Image1 SPIES XLINK Camera Control Unit (CCU) 93
  • Figure 3 51: Class 2 Device Recall Ureteroreno Videoscope & Fiberscope 94
  • Figure 3 52: Class 2 Device Recall A20975A: Working insert, with ramp, one way; A20976A: Bridge, one way; A20977A; Bridge, two way 94
  • Figure 3 53: Class 2 Device Recall Olympus High Frequency Resection Electrodes 94
  • Figure 3 54: Class 2 Device Recall Ureteroreno videoscope URFV2 and URFV2R 95
  • Figure 3 55: Class 2 Device Recall HF Cable WA00014A 95
  • Figure 3 56: Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence (Solyx) 96
  • Figure 3 57: Mid-Urethral Sling Tensioning Trial (MUST) 96
  • Figure 3 58: Prospective Registry for Patients Undergoing Surgery for Male Stress Urinary Incontinence 97
  • Figure 3 59: Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) (SOAP) 97
  • Figure 3 60: LithoVue Single Use Disposable Ureteroscope 98
  • Figure 3 61: Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope 98
  • Figure 3 62: Indwelling Stent Discoloration Project 99
  • Figure 3 63: Reduction of Stent Associated Morbidity by Minimizing Stent Material. 99
  • Figure 3 64: PROPPER Prospective Registry of Outcomes With Penile Prosthesis (PROPPER) 100
  • Figure 3 65: Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor 101
  • Figure 3 66: Foley Catheter vs a Self-contained Valved Urinary Catheter 101
  • Figure 3 67: Bladder Morphology Using 2 Different Catheter Designs 102
  • Figure 3 68: Outpatient Labor Induction With the Transcervical Foley Balloon 102
  • Figure 3 69: Medical and Economic Evaluation for Intermediate-risk Prostate Cancer (GETUGP05) 103
  • Figure 3 70: Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy 103
  • Figure 3 71: Product Evaluation of a Newly Developed Intermittent Catheter. 104
  • Figure 3 72: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheter in Healthy Volunteers 104
  • Figure 3 73: Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers 104
  • Figure 3 74: Virtue® European Study 105
  • Figure 3 75: Exploratory Study Investigating Urodynamic Parameters During Catheterisation 105
  • Figure 3 76: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence 105
  • Figure 3 77: The European Study of Altis Single Incision Sling System for Female Stress Urinary Incontinence (EASY) 106
  • Figure 3 78: Do Hydrophilic Catheters Decrease Pain and Discomfort of a Patient During Urodynamic Study (HYDRUDS) 106
  • Figure 3 79: Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients (ESCALE) 106
  • Figure 3 80: Ureteral Stent Study 107
  • Figure 3 81: Impact Ureteral Sheath Design During Ureteroscopy 107
  • Figure 3 82: Optimization of Ureterolysis During Hysterectomy 108
  • Figure 3 83: Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure 108
  • Figure 3 84: Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy 109
  • Figure 3 85: Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy 109
  • Figure 3 86: Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer (SINFRA_PROST) 110
  • Figure 3 87: Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy (BRAPROST) 110
  • Figure 3 88: Combined Treatment for Mixed Incontinence (ESTEEM) 111
  • Figure 3 89: TVT-ABBREVO Versus SERASIS for the Treatment of Female Urinary Stress Incontinence: 1 Year Outcomes of a Comparative Study With 2 Trans-obturator Sub Mid Urethral Slings 111
  • Figure 3 90: Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence 112
  • Figure 3 91: Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy 113
  • Figure 3 92: Low-Intensity Extracorporeal Shockwave Therapy and Vacuum Erectile Device as a Treatment for Peyronies Disease 113
  • Figure 3 93: Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients. 114
  • Figure 3 94: Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease 114
  • Figure 3 95: Narrow Versus Wide Focal Zones for Shock Wave Lithotripsy of Renal Calculi 114
  • Figure 3 96: Are the Stone Density and Location Useful Parameters for Small Kidney Stones? 115
  • Figure 3 97: Durability of Flexible Ureteroscopes and Causes of Infection During Flexible Ureterorenoscopy 115
  • Figure 3 98: Comparison of Different Energy Sources During TUR-P 115
  • Figure 3 99: Effects of Flexible Ureteroscopy on Renal Blood Flow 116
  • Figure 3 100: A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting 116
  • Figure 3 101: Blue Light Cystoscopy With Cysview® Registry (BLCCR) 116
  • Figure 3 102: Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors 117
  • Figure 3 103: Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes 117
  • Figure 3 104: T-DOC® 5 Fr Pediatric Clinical Investigation 118
  • Figure 3 105: Air vs Water Catheters (AvW (Bonn)) 118
  • Figure 3 106: A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use 119
  • Figure 3 107: Portable Pves Study 119
  • Figure 3 108: Ambulatory Pessary Trial 119
  • Figure 3 109: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Non-Silver vs Silver Coated Foley Catheters 120
  • Figure 3 110: Study to Compare CAUTI Rates Following ERASE CAUTI Tray Silver vs Silver Coated Foley Catheters 120
  • Figure 3 111: Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery 121
  • Figure 3 112: Quality of Life in Kidney Stone Patients Undergoing Surgery 121
  • Figure 3 113: Prostate Vaporization Techniques in Canadian Hospital 122
  • Figure 3 114: Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode 122
  • Figure 3 115: Assessment of Infection Control, Practice Efficiency, and Health Economics of Sheathed Versus Standard Cystoscopy 123
  • Figure 3 116: Results of Safety Guidewire Use in Ureteroscopic Stone Surgery 123
  • Figure 3 117: Transurethral En Bloc Versus Standard Resection of Bladder Tumour 123
  • Figure 3 118: PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors (PK Button) 124
  • Figure 4 1: Currency Exchange Rate, 2019 126
  • Figure 4 2: Urological Device Market by Segment, Australia, 2016 - 2026 (US$M) 128
  • Figure 4 3: Urological Device Market by Segment, Australia, 2016 - 2026 (AU$M) 129
  • Figure 4 4: Urological Device Market Growth by Segment, 2016 - 2026 134
  • Figure 4 5: Drivers and Limiters, Urological Device Market, Australia, 2019 139
  • Figure 4 6: Leading Competitors, Urological Device Market, Australia, 2019 145
  • Figure 4 7: SWOT Analysis, Boston Scientific, 2018 (1 of 2) 161
  • Figure 4 8: SWOT Analysis, Boston Scientific, 2018 (2 of 2) 162
  • Figure 4 9: SWOT Analysis, C. R. Bard (Becton Dickinson), 2018 (1 of 2) 163
  • Figure 4 10: SWOT Analysis, C. R. Bard (Becton Dickinson), 2018 (2 of 2) 164
  • Figure 4 11: SWOT Analysis, Coloplast, 2018 165
  • Figure 4 12: SWOT Analysis, Cook Medical, 2018 (1 of 2) 166
  • Figure 4 13: SWOT Analysis, Cook Medical, 2018 (2 of 2) 167
  • Figure 4 14: SWOT Analysis, Ethicon, 2018 168
  • Figure 4 15: SWOT Analysis, Karl Storz, 2018 169
  • Figure 4 16: SWOT Analysis, Laborie, 2018 170
  • Figure 4 17: SWOT Analysis, Olympus, 2018 (1 of 2) 171
  • Figure 4 18: SWOT Analysis, Olympus, 2018 (2 of 2) 172
  • Figure 5 1: Procedure Codes Investigated, Australia, 2019 (1 of 2) 174
  • Figure 5 2: Procedure Codes Investigated, Australia, 2019 (2 of 2) 175
  • Figure 5 3: Urological Procedures by Type, Australia, 2016 - 2026 176
  • Figure 5 4: Urinary Incontinence Procedures by Type, Australia, 2016 - 2026 180
  • Figure 5 5: Male Incontinence Management Procedures by Type, Australia, 2016 - 2026 183
  • Figure 5 6: Female Incontinence Management Procedures by Type, Australia, 2016 - 2026 186
  • Figure 5 7: Pelvic Organ Prolapse Repair Procedures by Type, Australia, 2016 - 2026 188
  • Figure 5 8: Stone Management Procedures by Type, Australia, 2016 - 2026 190
  • Figure 5 9: ESWL Procedures, Australia, 2016 - 2026 192
  • Figure 5 10: Transurethral Procedures by Type, Australia, 2016 - 2026 194
  • Figure 5 11: Ureteral Stent Placement Procedures, Australia, 2016 - 2026 196
  • Figure 5 12: PCNL Procedures, Australia, 2016 - 2026 198
  • Figure 5 13: BPH Procedures by Type, Australia, 2016 - 2026 201
  • Figure 5 14: Prostatectomy Procedures by Type, Australia, 2016 - 2026 203
  • Figure 5 15: Erectile Dysfunction Management Procedures by Type, Australia, 2016 - 2026 206
  • Figure 6 1: Urinary Incontinence Device Market by Segment, Australia, 2016 - 2026 (US$M) 210
  • Figure 6 2: Urinary Incontinence Device Market by Segment, Australia, 2016 - 2026 (AU$M) 210
  • Figure 6 3: Urinary Catheter Market by Segment, Australia, 2016 - 2026 (US$M) 215
  • Figure 6 4: Urinary Catheter Market by Segment, Australia, 2016 - 2026 (AU$M) 215
  • Figure 6 5: Intermittent Catheter Market, Australia, 2016 - 2026 217
  • Figure 6 6: Foley Catheter Market, Australia, 2016 - 2026 219
  • Figure 6 7: Male External Catheter Market, Australia, 2016 - 2026 221
  • Figure 6 8: Urethral Bulking Agent Market by Segment, Australia, 2016 - 2026 (US$M) 223
  • Figure 6 9: Urethral Bulking Agent Market by Segment, Australia, 2016 - 2026 (AU$M) 224
  • Figure 6 10: Total Urethral Bulking Agent Market, Australia, 2016 - 2026 225
  • Figure 6 11: Male Urethral Bulking Agent Market, Australia, 2016 - 2026 227
  • Figure 6 12: Female Urethral Bulking Agent Market, Australia, 2016 - 2026 229
  • Figure 6 13: Incontinence Management Device Market by Segment, Australia, 2016 - 2026 (US$M) 232
  • Figure 6 14: Incontinence Management Device Market by Segment, Australia, 2016 - 2026 (AU$M) 232
  • Figure 6 15: Female Incontinence Sling Market by Type, Australia, 2016 - 2026 (US$M) 235
  • Figure 6 16: Female Incontinence Sling Market by Type, Australia, 2016 - 2026 (AU$M) 236
  • Figure 6 17: Total Female Incontinence Sling Market, Australia, 2016 - 2026 238
  • Figure 6 18: Transvaginal Tape Female Incontinence Sling Market, Australia, 2016 - 2026 240
  • Figure 6 19: Transobturator Female Incontinence Sling Market, Australia, 2016 - 2026 242
  • Figure 6 20: Single-Incision Female Incontinence Sling Market, Australia, 2016 - 2026 244
  • Figure 6 21: Male Implantable Incontinence Device Market by Segment, U.S., 2016 - 2026 (US$M) 247
  • Figure 6 22: Male Implantable Incontinence Device Market by Segment, U.S., 2016 - 2026 (AU$M) 247
  • Figure 6 23: Total Male Implantable Incontinence Device Market, Australia, 2016 - 2026 249
  • Figure 6 24: Male Incontinence Sling Market, Australia, 2016 - 2026 251
  • Figure 6 25: Male Artificial Urinary Sphincter Market, Australia, 2016 - 2026 253
  • Figure 6 26: Drivers and Limiters, Urinary Incontinence Device Market, U.S., 2018 257
  • Figure 6 27: Leading Competitors, Urinary Incontinence Device Market, Australia, 2018 262
  • Figure 7 1: Devices Included in the Australian Register of Therapeutic Good Administration, Effective January 2018 (1 of 2) 266
  • Figure 7 2: Devices Included in the Australian Register of Therapeutic Good Administration, Effective January 2018 (2 of 2) 267
  • Figure 7 3: Pelvic Organ Prolapse Repair Device Market by Segment, Australia, 2016 - 2026 (US$M) 270
  • Figure 7 4: Pelvic Organ Prolapse Repair Device Market by Segment, Australia, 2016 - 2026 (AU$M) 270
  • Figure 7 5: Total Pelvic Organ Prolapse Repair Device Market, Australia, 2016 - 2026 274
  • Figure 7 6: Transvaginal Mesh Market, Australia, 2016 - 2026 277
  • Figure 7 7: Sacrocolpopexy Mesh Market, Australia, 2016 - 2026 279
  • Figure 7 8: Drivers and Limiters, Pelvic Organ Prolapse Repair Device Market, Australia, 2019 282
  • Figure 7 9: Leading Competitors, Pelvic Organ Prolapse Repair Market, Australia, 2019 285
  • Figure 8 1: Stone Management Device Market by Segment, Australia, 2016 - 2026 (US$M) 291
  • Figure 8 2: Stone Management Device Market by Segment, Australia, 2016 - 2026 (AU$M) 292
  • Figure 8 3: ESWL Equipment Market, Australia, 2016 - 2026 297
  • Figure 8 4: ISWL Equipment Market, U.S., 2016 - 2026 299
  • Figure 8 5: Holmium Laser Market by Segment, Australia, 2016 - 2026 (US$M) 301
  • Figure 8 6: Holmium Laser Market by Segment, Australia, 2016 - 2026 (AU$M) 302
  • Figure 8 7: Holmium Laser Equipment Market, Australia, 2016 - 2026 304
  • Figure 8 8: Holmium Laser Fiber Market, Australia, 2016 - 2026 307
  • Figure 8 9: Stone Fragment Retrieval Device Market by Segment, Australia, 2016 - 2026 (US$M) 309
  • Figure 8 10: Stone Fragment Retrieval Device Market by Segment, Australia, 2016 - 2026 (AU$M) 310
  • Figure 8 11: Total Stone Fragment Retrieval Device Market, Australia, 2016 - 2026 312
  • Figure 8 12: Nitinol Stone Fragment Retrieval Device Market, Australia, 2016 - 2026 314
  • Figure 8 13: Stainless Steel Stone Fragment Retrieval Device Market, Australia, 2016 - 2026 316
  • Figure 8 14: Ureteral Stent Market, Australia, 2016 - 2026 318
  • Figure 8 15: Ureteral Guidewire Market, Australia, 2016 - 2026 320
  • Figure 8 16: Drivers and Limiters, Stone Management Device Market, Australia, 2019 324
  • Figure 8 17: Leading Competitors, Stone Management Device Market, Australia, 2019 329
  • Figure 9 1: BPH Treatment Device Market by Segment, U.S., 2016 - 2026 (US$M) 336
  • Figure 9 2: BPH Treatment Device Market by Segment, U.S., 2016 - 2026 (AUS$M) 336
  • Figure 9 3: TURP Market by Segment, Australia, 2016 - 2026 (US$M) 341
  • Figure 9 4: TURP Market by Segment, Australia, 2016 - 2026 (AUS$M) 341
  • Figure 9 5: Monopolar Electrode Market, Australia, 2016 - 2026 343
  • Figure 9 6: Bipolar Electrode Market, U.S., 2016 - 2026 345
  • Figure 9 7: Laser BPH Market by Segment, Australia, 2016 - 2026 (US$M) 348
  • Figure 9 8: Laser BPH Market by Segment, Australia, 2016 - 2026 (AUS$M) 348
  • Figure 9 9: Laser BPH Equipment Market, Australia, 2016 - 2026 350
  • Figure 9 10: Laser BPH Fiber Market, Australia, 2016 - 2026 352
  • Figure 9 11: UroLift Market, Australia, 2016 - 2026 354
  • Figure 9 12: Rezum Market, Australia, 2016 - 2026 356
  • Figure 9 13: Drivers and Limiters, BPH Treatment Device Market, Australia, 2019 361
  • Figure 9 14: Leading Competitors, BPH Treatment Device Market, Australia, 2019 364
  • Figure 10 1: Erectile Dysfunction Device Market by Segment, Australia, 2016 - 2026 (US$M) 368
  • Figure 10 2: Erectile Dysfunction Device Market by Segment, Australia, 2016 - 2026 (AUS$M) 369
  • Figure 10 3: Inflatable Erectile Dysfunction Device Market, Australia, 2016 - 2026 374
  • Figure 10 4: Malleable Erectile Dysfunction Device Market, Australia, 2016 - 2026 376
  • Figure 10 5: Vacuum Erection Device Market, Australia, 2016 - 2026 378
  • Figure 10 6: Drivers and Limiters, Erectile Dysfunction Device Market, Australia, 2019 381
  • Figure 10 7: IIEF-5 Comparison for Penile Implant 383
  • Figure 10 8: Leading Competitors, Erectile Dysfunction Device Market, Australia, 2019 384
Back to Top